Start Date
November 30, 2005
Primary Completion Date
October 31, 2006
Study Completion Date
October 31, 2006
RC-1291 HCl
Placebo
Center for Cancer and Blood Disorders, Bethesda
South Carolina Oncology Associates, Columbia
Charleston Cancer Center, Charleston
South Carolina Cancer Specialists, Hilton Head Island
Melbourne Internal Medicine Associates, Melbourne
Osler Medical, Inc./ Osler Clinical Research, Melbourne
PAB Clinical Research, Brandon
Bay Area Oncology, Tampa
Hematology Oncology Consultants, Inc., Columbus
University of Texas Medical Texas, Galveston
Palo Verde Hematology Oncology Ltd., Glendale
Kenmar Clinical Research, Los Angeles
Kenmar Research Institute, Los Angeles
Sant Chawla, Inc., Santa Monica
Pacific Oncology & Hematology Associates, Encinitas
Pacific Oncology and Hematology Associates, Encinitas
Comprehensive Blood & Cancer Center, Bakersfield
Advanced Medical Research Institute, Fresno
Multicare Health System, Tacoma
Helsinn Therapeutics (U.S.), Inc
INDUSTRY